Literature DB >> 16809897

Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose.

Amy Barton Pai1, Manjunath P Pai, Joseph Depczynski, Charles R McQuade, Renee-Claude Mercier.   

Abstract

BACKGROUND: Hemodialysis vascular access infections are most frequently caused by Staphylococcus spp. The purpose of this study was to determine if S. aureus growth is enhanced after administration of IV iron sucrose and to establish a relationship between the appearance of non-transferrin-bound iron (NTBI) and S. aureus growth.
METHODS: Serum samples were obtained from 12 hemodialysis patients receiving maintenance doses of 100 mg of iron sucrose at baseline and 5, 30, 90, 220 min and 48 h after iron administration. Assays for NTBI and transferrin saturation were performed. S. aureus isolates were used to inoculate patient serum samples. Bacterial growth was determined by optical density.
RESULTS: Six of 12 patients had NTBI present within 30 min of the iron dose. NTBI was present more frequently in patients with baseline transferrin saturation values >30% (p < 0.05). Bacterial growth was significantly greater in patients who had NTBI present at 5, 90 and 220 min after iron administration compared to those who did not have NTBI present.
CONCLUSIONS: Doses of 100 mg of iron sucrose are associated with the presence of NTBI and enhanced S. aureus growth. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809897     DOI: 10.1159/000094343

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  13 in total

1.  Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation.

Authors:  Eldad A Hod; Ning Zhang; Set A Sokol; Boguslaw S Wojczyk; Richard O Francis; Daniel Ansaldi; Kevin P Francis; Phyllis Della-Latta; Susan Whittier; Sujit Sheth; Jeanne E Hendrickson; James C Zimring; Gary M Brittenham; Steven L Spitalnik
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

Review 2.  Considerations and challenges in defining optimal iron utilization in hemodialysis.

Authors:  David M Charytan; Amy Barton Pai; Christopher T Chan; Daniel W Coyne; Adriana M Hung; Csaba P Kovesdy; Steven Fishbane
Journal:  J Am Soc Nephrol       Date:  2014-12-26       Impact factor: 10.121

Review 3.  The Labile Side of Iron Supplementation in CKD.

Authors:  Itzchak Slotki; Zvi Ioav Cabantchik
Journal:  J Am Soc Nephrol       Date:  2015-05-21       Impact factor: 10.121

4.  Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy.

Authors:  Meera R Chappidi; Heather J Chalfin; Daniel J Johnson; Max Kates; Nikolai A Sopko; Michael H Johnson; Jen-Jane Liu; Steven M Frank; Trinity J Bivalacqua
Journal:  Urol Oncol       Date:  2016-10-19       Impact factor: 3.498

5.  Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia.

Authors:  Dante A Suffredini; Wanying Xu; Junfeng Sun; Jesús Barea-Mendoza; Steven B Solomon; Samuel L Brashears; Andreas Perlegas; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson; Irene Cortés-Puch
Journal:  Transfusion       Date:  2017-06-27       Impact factor: 3.157

Review 6.  Safety of intravenous iron in hemodialysis patients.

Authors:  Xiaojuan Li; Abhijit V Kshirsagar; M Alan Brookhart
Journal:  Hemodial Int       Date:  2017-04-03       Impact factor: 1.812

7.  Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia.

Authors:  Dong Wang; Irene Cortés-Puch; Junfeng Sun; Steven B Solomon; Tamir Kanias; Kenneth E Remy; Jing Feng; Meghna Alimchandani; Martha Quezado; Christine Helms; Andreas Perlegas; Mark T Gladwin; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson
Journal:  Transfusion       Date:  2014-03-03       Impact factor: 3.157

Review 8.  Non transferrin bound iron: nature, manifestations and analytical approaches for estimation.

Authors:  Meghna Patel; D V S S Ramavataram
Journal:  Indian J Clin Biochem       Date:  2012-08-31

9.  Endotoxin binding by sevelamer: potential impact on nutritional status.

Authors:  Natsuki Kubotera; Alexander J Prokopienko; Adinoyi O Garba; Amy Barton Pai
Journal:  Int J Nephrol       Date:  2013-01-17

10.  Nanoparticulate iron(III) oxo-hydroxide delivers safe iron that is well absorbed and utilised in humans.

Authors:  Dora I A Pereira; Sylvaine F A Bruggraber; Nuno Faria; Lynsey K Poots; Mani A Tagmount; Mohamad F Aslam; David M Frazer; Chris D Vulpe; Gregory J Anderson; Jonathan J Powell
Journal:  Nanomedicine       Date:  2014-06-28       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.